Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
It means that as a standalone oral therapy at the tested doses, it did not produce the magnitude of weight loss that pharmaceutical companies require for commercial viability
The answer is that it really depends, but in my experience, MOST patients are fine to use subcutaneous injection-sized needles
A minus 2.5% work RVU efficiency adjustment also applies to established codes like 96372, which slightly reduces the work RVU component used in the payment calculation
Presented for research literature review only Lu X et al
US$ 22.51
US$ 26.61
US$ 25.33
